PRESS RELEASE published on 02/06/2024 at 16:00, 2 years 6 months ago Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease Cantabio Pharmaceuticals, Inc. receives major grant from MJFF for the development of DJ-1 replacement therapy aimed at treating Parkinson's disease by increasing DJ-1 levels in patients and preventing disease progression Precision Medicine Cantabio Pharmaceuticals MJFF Grant DJ-1 Replacement Therapy Parkinson's Disease
Published on 08/31/2026 at 22:15, 8 minutes ago Namibia Critical Metals Provides Update on Lofdal Joint Venture Transaction
Published on 08/31/2026 at 22:00, 23 minutes ago NV Gold Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 08/31/2026 at 17:22, 5 hours 1 minute ago ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison
Published on 08/31/2026 at 15:50, 6 hours 33 minutes ago Sarama Resources - Grant of Equity Incentives
Published on 08/31/2026 at 15:00, 7 hours 23 minutes ago Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
Published on 08/31/2026 at 22:07, 15 minutes ago VIB Vermögen AG with successful Annual General Meeting and effective control and profit transfer agreement
Published on 08/31/2026 at 19:31, 2 hours 52 minutes ago DEAG reports strong results for the first half of 2026
Published on 08/31/2026 at 19:15, 3 hours 7 minutes ago CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region
Published on 08/31/2026 at 18:20, 4 hours 3 minutes ago CPI PROPERTY GROUP publishes financial results for the first half of 2026
Published on 08/31/2026 at 18:06, 4 hours 16 minutes ago MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026
Published on 08/31/2026 at 17:45, 4 hours 38 minutes ago Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 12:00, 10 hours 23 minutes ago Capital increase through exercise of subscription rights
Published on 08/31/2026 at 07:00, 15 hours 23 minutes ago Biophytis strengthens its financial position and extends its cash runway into Q1 2027